Lates News

Atossa Therapeutics (ATOS.US): In the third quarter of 2025, the revenue of 0 US dollars was achieved, the previous value was 0 US dollars; earnings per share was -0.07 US dollars, the previous value was -0.06 US dollars, and the expected value was -0.07 US dollars.